Shanghai Pharmaceuticals Controlling Shareholder Plans H-Share Purchase
Shanghai Pharmaceuticals said its controlling shareholder plans to increase its holdings of the company’s H shares.
Related stories
Autohome Reports Q3 Operating Profit of RMB 95.7 Million
M impact | EQUITY | Nov 04, 2026, 09:30 AM UTC
Autohome Announces Unaudited Third-Quarter 2026 Results
M impact | EQUITY | Nov 04, 2026, 09:30 AM UTC
Autohome Reports Q3 Revenue of RMB 1,315 Million
M impact | EQUITY | Nov 04, 2026, 09:30 AM UTC
AudioCodes reports Q3 results, revenue rises 4.2%
AudioCodes reported Q3 non-GAAP EPS of $0.16, matching FactSet consensus. Revenue increased 4.2% year over year to $64.
M impact | EQUITY | Nov 04, 2026, 09:29 AM UTC
Navitas shares rise 7.6% premarket after Q3 revenue beats estimates
M impact | EQUITY | Nov 04, 2026, 09:29 AM UTC
Siltronic CFO Says Energy Prices Could Be a Headwind Next Year
Siltronic's CFO said energy prices at the current level would create a headwind next year.
M impact | EQUITY | Nov 04, 2026, 09:29 AM UTC